Mopac Uses

How old is patient?
sponsored

What is Mopac?

Mopac is used to help prevent the symptoms of asthma and improve breathing in patients 4 years of age and older. When used regularly every day, inhaled Mopac decreases the number and severity of asthma attacks. However, it will not relieve an asthma attack that has already started.

Mopac HFA is used as a maintenance treatment for the prevention and control of asthma symptoms in patients 12 years of age and older.

Inhaled Mopac belongs to the family of medicines known as corticosteroids (cortisone-like medicines). It works by preventing certain cells in the lungs and breathing passages from releasing substances that cause asthma symptoms.

Mopac is available only with your doctor's prescription.

Mopac indications

sponsored

Mopac is a cortisone-like steroid available in cream, ointment, and lotion form. It is used to treat certain itchy rashes and other inflammatory skin conditions.

How should I use Mopac?

Use Mopac spray as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Mopac spray.

Uses of Mopac in details

sponsored

Mopac is used to treat used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis. It is also used to relieve symptoms of hay fever, allergies of nose and nasal polyps (fleshy swelling inside the nose).

Mopac description

Mopac is a medium-potency synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Studies in asthmatic patients have demonstrated that Mopac provides a favorable ratio of topical to systemic activity due to its primary local effect along with the extensive hepatic metabolism and the lack of active metabolites. Though effective for the treatment of asthma, glucocorticoids do not affect asthma symptoms immediately. Maximum improvement in symptoms following inhaled administration of Mopac furoate may not be achieved for 1 to 2 weeks or longer after starting treatment. The anti-inflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes.

Mopac dosage

sponsored

Mopac Dosage

Applies to the following strength(s): 220 mcg/inh; 110 mcg/inh; 100 mcg/inh; 200 mcg/inh

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Asthma - Maintenance

Inhalation Aerosol Powder:

Previous therapy with bronchodilators alone, or inhaled corticosteroids:

-Initial dose: 220 mcg inhaled orally in the evening

-Maximum dose: 440 mcg in divided doses of 220 mcg twice a day, or as 440 mcg once daily.

Previous therapy with oral corticosteroids:

-Initial dose: 440 mcg inhaled orally twice a day

-Maximum dose: 880 mcg

Inhalation Aerosol:

Previous therapy with inhaled medium-dose corticosteroids:

-2 inhalations of 100 mcg orally twice a day

Previous therapy with inhaled high-dose or oral corticosteroids:

-2 inhalations of 200 mcg orally twice a day

-Maximum dose: 800 mcg per day

For Patients Currently Receiving Chronic

Oral Corticosteroid Therapy

:

-Prednisone should be weaned slowly, beginning after at least 1 week of therapy with this drug.

-Monitor for signs of asthma instability, including serial objective measures of airflow, and for signs of adrenal insufficiency during steroid taper and following discontinuation of oral corticosteroid therapy.

Comments:

-The time to onset and degree of symptom relief varies based on individual patient.

-Maximum benefit may not be achieved for 1 week or longer.

-After asthma stability has been achieved, titrate to the lowest effective dosage to reduce side effects.

-If there is no response to the starting dose after 2 weeks of therapy, higher doses may provide additional asthma control.

-Re-evaluate therapy and consider additional therapeutic options (e.g., initiating an inhaled corticosteroid and long-acting beta2-agonist combination product, or initiating oral corticosteroids) if asthma control is not achieved.

-Doses above the recommended should not be used.

Use: Maintenance treatment of asthma as prophylactic therapy

Usual Pediatric Dose for Asthma - Maintenance

Inhalation Aerosol Powder:

Less than 4 years: Not approved for this age.

4 to 11 years:

-110 mcg orally once a day, in the evening

12 years and older:

Previous therapy with bronchodilators alone or inhaled corticosteroids:

-Initial dose: 220 mcg inhaled orally in the evening

-Maximum dose: 440 mcg in divided doses of 220 mcg twice a day, or as 440 mcg once daily.

Previous therapy with oral corticosteroids:

-Initial dose: 440 mcg inhaled orally twice a day

-Maximum dose: 880 mcg

Inhalation Aerosol:

Less than 12 years: Not approved for this age.

12 years or older:

Previous therapy with inhaled medium-dose corticosteroids:

-2 inhalations of 100 mcg orally twice a day

Previous therapy with inhaled high-dose or oral corticosteroids:

-2 inhalations of 200 mcg orally twice a day

-Maximum dose: 800 mcg per day

For Patients Currently Receiving Chronic

Oral Corticosteroid Therapy

:

-Prednisone should be weaned slowly, beginning after at least 1 week of therapy with this drug.

-Monitor for signs of asthma instability, including serial objective measures of airflow, and for signs of adrenal insufficiency during steroid taper and following discontinuation of oral corticosteroid therapy

Comments:

-The time to onset and degree of symptom relief varies based on individual patient.

-Maximum benefit may not be achieved for 1 week or longer.

-After asthma stability has been achieved, titrate to the lowest effective dosage to reduce side effects.

-For patients older than 12 years, if there is no response to the starting dose after 2 weeks of therapy, higher doses may provide additional asthma control.

-Re-evaluate therapy and consider additional therapeutic options (e.g., initiating an inhaled corticosteroid and long-acting beta2-agonist combination product, or initiating oral corticosteroids) if asthma control is not achieved.

-Doses above the recommended should not be used.

Use: Maintenance treatment of asthma as prophylactic therapy

Renal Dose Adjustments

No adjustment recommended.

Liver Dose Adjustments

No adjustment recommended.

Dose Adjustments

The dose of Mopac should be individualized and titrated to the lowest effective dose for the control of asthma.

Precautions

Inhalation aerosol powder: Safety and efficacy have not been established in patients younger than 4 years.

Inhalation aerosol: Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

-For oral inhalation only.

-Inhale rapidly and deeply.

-After each inhalation, rinse mouth with water without swallowing.

-Once a day dose should be taken only in the evening.

-If a dose is missed, take the next dose at the regular time.

Reconstitution/preparation techniques:

-The pressurized metered dose aerosol inhaler should be primed before using for the first time and if not used for more than 5 days.

-To prime the pressurized aerosol, release 4 test sprays into the air, away from the face, shaking well before each spray.

-The manufacturer product information should be consulted.

General:

-Limitations of Use: This drug is not indicated for the relief of acute bronchospasm.

-This drug is not a bronchodilator and should not be used to treat status asthmaticus or to relieve acute asthma symptoms.

-Acute asthma symptoms should be treated with an inhaled, short-acting beta2-agonist.

Monitoring:

-Respiratory: Asthma signs, symptoms, instability

-Gastrointestinal: Signs of adverse effect on the oral cavity

-Musculoskeletal: Decrease in bone mineral density (BMD), growth in pediatric patients

-Ocular: Changes in vision, increase of intraocular pressure, glaucoma, cataracts

Patient advice:

-Use this drug at regular intervals, since its effectiveness depends on regular use.

-Contact physician if symptoms get worse, more inhalation of the rescue inhaler than usual is needed, significant decrease in lung function as outlined by the physician.

-Therapy with this drug should not be stopped without physician advice since symptoms may recur after discontinuation.

More about Mopac

Consumer resources

Professional resources

Related treatment guides

Mopac interactions

sponsored

Possible food and drug interactions when taking Mopac furoate:

No interactions have been noted.

Mopac side effects

See also:
What are the possible side effects of Mopac?

Applies to Mopac nasal: nasal spray

In addition to its needed effects, some unwanted effects may be caused by Mopac nasal. In the event that any of these side effects do occur, they may require medical attention.

Major Side Effects

You should check with your doctor immediately if any of these side effects occur when taking Mopac nasal:

More common:

Less common: Rare Incidence not known:

Minor Side Effects

Some of the side effects that can occur with Mopac nasal may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common:

Less common: Incidence not known:

Mopac contraindications

See also:
What is the most important information I should know about Mopac?

Hypersensitivity to Mopac furoate or to other corticosteroids. Rosacea, acne vulgaris, skin atrophy, inflammation around the mouth, TB, ulcerated skin or wounds, genital itching, diaper rash, viral infection (cold sores, chickenpox, shingles), fungal skin infection (thrush, tinea/ringworm), other skin infections. Childn <2 yr.

Active ingredient matches for Mopac:

Mometasone in Ecuador.


List of Mopac substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD
Moskyn 0.1% w/w OINT / 5g (Win Medicare)$ 0.84
MOSKYN oint 0.1 % w/w x 5g (Win Medicare)$ 0.84
Mosone 1 mg/1 g x 5 g (Olcare (Olski))
Mosone 1 mg/1 g x 10 g (Olcare (Olski))
Mosone 1 mg/1 g x 15 g (Olcare (Olski))
Mosone 1 mg/1 g x 5 g x 1's (Olcare (Olski))
MOSONE 1MG CREAM 1 tube / 5 GM cream each (Olcare (Olski))$ 0.89
MOSONE cream 1 mg x 1 g x 10g (Olcare (Olski))$ 0.90
MOSONE cream 1 mg x 1 g x 30g (Olcare (Olski))$ 1.55
Mosone 1mg Cream (Olcare (Olski))$ 0.89
Motaderm 0.1 % x 5 g x 1's (Bernofarm)$ 4.43
Motaderm 0.1 % x 10 g x 1's (Bernofarm)$ 6.82
Motaneal cream 0.1% 5 g x 1's (Bayer Thai)
Mtaz 2% CRM / 15g (Wallace (Rivella))$ 1.20
MTAZ 0.1% CREAM 1 tube / 15 GM cream each (Wallace (Rivella))$ 1.58
MTAZ 0.10% CREAM 1 tube / 5 GM cream each (Wallace (Rivella))$ 0.77
MTAZ cream 2 % x 15g (Wallace (Rivella))$ 1.20
Mtaz 0.1% Cream (Wallace (Rivella))$ 1.73
Mtaz 0.10% Cream (Wallace (Rivella))$ 0.77
Murozo 0.1 % x 10 mL
Murozo 0.1 % x 30 mL

References

  1. PubChem. "Mometasone". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  2. DrugBank. "Mometasone". http://www.drugbank.ca/drugs/DB00764 (accessed September 17, 2018).
  3. MeSH. "Anti-Allergic Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Mopac are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Mopac. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


2 consumers reported age

Users%
16-291
50.0%
46-601
50.0%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 9 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved